Patients with schizophrenia report that negative symptoms significantly impair work performance and interpersonal relationships.

Subcutaneous autoinjector formulation expands starting treatment options for mild cognitive impairment and mild dementia due to Alzheimer disease.

Among NFL players who died between 2016 and 2021, around 25% of players had chronic traumatic encephalopathy (CTE) at death.

Looming cognitive style directly affects anxiety, but influences depression through rumination among undergraduate students.

Small changes to night-shift hours appear to improve sleep quality and inflammatory biomarkers among emergency medicine physicians.

Organophosphate pesticide exposure is not associated with autism-related traits through the prenatal or early childhood period of life.

Only 3 of the 1357 FDA-authorized artificial intelligence medical devices have been evaluated for clinical effectiveness.

In a subgroup analysis, among those aged younger than 20 years, there was no difference in earlier age at onset of psychosis between cannabis users and nonusers; however, there were age-related ...

Early-life immune activation from bacterial or viral infections may increase the risk for psychiatric disorders in childhood and adolescence.

Severe mental illness is linked to a higher risk for premature death from physical illnesses like cardiovascular and respiratory diseases.

The FDA granted Priority Review to Teva's NDA for ecopipam, a selective D1 antagonist for pediatric Tourette syndrome.